RETRACTABLE TECHNOLOGIES, INC. REPORTS PROCEEDS FROM BECTON DICKINSON LITIGATION SETTLEMENT LITTLE ELM, Texas, July 22, 2004—Retractable Technologies, Inc. (AMEX: RVP) announced today that it has received approximately $65.1 million on a pre-tax basis from the $100 million cash settlement of its federal antitrust lawsuit against Becton Dickinson and Company, Inc.

RETRACTABLE TECHNOLOGIES, INC. DECLARES DIVIDENDS TO SERIES I AND II CLASS B SHAREHOLDERS LITTLE ELM, Texas, July 20, 2004—Retractable Technologies, Inc. (AMEX: RVP) announced today that its board of directors has declared dividends to holders of Series I Class B (“Series I”) and Series II Class B (“Series II”) Convertible

RETRACTABLE TECHNOLOGIES, INC. SETTLES ANTITRUST SUIT AGAINST BECTON DICKINSON (BD) FOR $100 MILLION IN CASH LITTLE ELM, Texas, July 2, 2004—Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, today announced that it has settled its longstanding federal antitrust suit against Becton Dickinson (BD) for $100 million

RETRACTABLE TECHNOLOGIES, INC. SETTLES PATENT INFRINGEMENT SUIT AGAINST NEW MEDICAL TECHNOLOGY (NMT) LITTLE ELM, Texas, April 29, 2004—Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, today announced that it has settled its patent infringement lawsuit against New Medical Technology, Inc. (NMT, Inc.) and affiliates for $1

RETRACTABLE TECHNOLOGIES, INC. REPORTS 2003 DILUTED EARNINGS PER SHARE OF $0.20 LITTLE ELM, Texas, April 06, 2004—Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, today reported diluted earnings per share of $0.20 for the year ended December 31, 2003, compared with a loss per share of

RETRACTABLE TECHNOLOGIES PRAISES CONGRESSIONAL ACTION REQUIRING SAFETY SYRINGES IN GLOBAL AIDS BILL LITTLE ELM, TX—Thomas J. Shaw, president and CEO of Retractable Technologies, Inc., a leading maker of automated retraction safety needle devices, today applauded Congress for requiring that syringes provided to Africa under the Global AIDS initiative include safety

RETRACTABLE TECHNOLOGIES, INC. ANNOUNCES POSTPONEMENT OF ANTITRUST TRIAL UNTIL JULY 2004 LITTLE ELM, TEXAS — Retractable Technologies, Inc. (AMEX: RVP) (Retractable) said today that the federal district court in Texarkana, Texas has issued an order postponing the trial in its civil antitrust lawsuit against Becton Dickinson (BD) until July 6,

Frost & Sullivan Names Retractable Technologies Inc. Recipient of 2003 Product Quality Leadership Award PALO ALTO, Calif.–Frost & Sullivan, a leader in growth consulting, today named Retractable Technologies Inc. (AMEX:RVP), which manufactures and markets the VanishPoint® line of automated retraction safety needle devices, as the recipient of its 2003 Product

Retractable Technologies, Inc. Reports Fully Diluted Earnings Per Share of $0.30 for the Nine Months Ended September 30, 2003 LITTLE ELM, Texas–Retractable Technologies, Inc. (AMEX:RVP), a leading maker of safety needle devices, reported a loss per share of $0.12 for the three-month period ended September 30, 2003, and diluted earnings

RETRACTABLE TECHNOLOGIES, INC. ANNOUNCES INTENT TO TERMINATE MARKETING AGREEMENT WITH ABBOTT LABORATORIES LITTLE ELM, Texas, Aug. 29, 2003 Retractable Technologies, Inc. (AMEX: RVP) a leading maker of safety needle devices, today announced that it has notified Abbott Laboratories that it intends to terminate its National Marketing and Distribution Agreement with